Anti-TNF Withdrawal in Inflammatory Bowel Disease

The introduction of the anti-tumor necrosis factorα agents (anti-TNFα) in clinical practice has greatly advanced the treatment of inflammatory bowel disease. The use of these medications results in durable remission in a subset of patients, preventing surgery and hospitalizations. However, there a...

Full description

Bibliographic Details
Main Author: Torres,Joana (author)
Other Authors: Cravo,Marília (author), Colombel,Jean-Frédéric (author)
Format: article
Language:eng
Published: 2016
Subjects:
Inflammatory Bowel Diseases/drug therapy
Tumor Necrosis Factor-Alpha/antagonists and inhibitors
Tumor Necrosis Factor-Alpha/therapeutic use
Withholding Treatment
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452016000300006
Country:Portugal
Oai:oai:scielo:S2341-45452016000300006

Internet

http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452016000300006

Similar Items